Skip to main content
BIO PROTECH INC. logo

BIO PROTECH INC. — Investor Relations & Filings

Ticker · 199290 ISIN · KR7199290008 LEI · 988400TYKP3J6SZOGR02 KO Manufacturing
Open in API
Filings indexed 281 across all filing types
Latest filing 2022-12-15 Regulatory Filings
Country KR South Korea
Listing KO 199290

About BIO PROTECH INC.

https://www.protechsite.com/

BIO PROTECH INC. is a manufacturer of medical equipment and disposable supplies. The company develops and produces a range of products for applications in surgery, cardiology, neurology, and pain management. Its portfolio includes electrosurgical devices such as smoke evacuators and surgical pencils, various electrocardiogram (ECG) electrodes, and transcutaneous electrical nerve stimulation (TENS) units. The company specializes in bio-medical sensors and related products developed using advanced skin technology for the global healthcare market.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory announcement regarding corporate governance procedures, it fits best under the RNS category.
2022-12-15 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocated capital increase/rights issue). It details the type of security (convertible redeemable preferred shares), the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2022-12-12 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding a decision to issue new shares through a third-party allocation (유상증자결정). This type of filing is a standard regulatory disclosure for capital changes and share issuance in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2022-11-25 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '임시주주총회 결과' (Extraordinary General Meeting Results) and details the outcome of a shareholder vote regarding the reappointment of a director. This falls directly under the definition of a Declaration of Voting Results.
2022-10-27 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 1% confidence The document is a formal notification regarding the results of an Investor Relations (IR) meeting held by BioProtech. It details the date, location, attendees, and agenda of the meeting. Since it is a short regulatory announcement confirming that an IR event took place and where the materials were posted, rather than the presentation slides themselves, it falls under the category of a regulatory filing or announcement of an event.
2022-10-27 Korean
기타주요경영사항(내부결산실적등)(자율공시)
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (BioProtech) titled 'Other Major Management Matters (Internal Financial Results)'. It provides a summary table of quarterly financial performance (revenue, operating profit, net income) for the 3rd quarter of 2022. Since this is an initial announcement of quarterly financial results (key highlights only) rather than a full comprehensive report, it falls under the 'Earnings Release' category. Q3 2022
2022-10-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.